R
Raidium
Raidium foundation model: Radiology augmented GPT to tackle the complexity of precision medicine
About Raidium
Raidium is a cutting-edge startup operating in the healthcare technology sector, specifically focusing on radiology. The company leverages advanced Artificial Intelligence (AI) to enhance precision medicine by improving the characterization of imaging biomarkers. Imaging biomarkers are measurable indicators found in medical images that can help diagnose and monitor diseases. Raidium's AI platform is designed to assist radiologists, who often face the challenge of analyzing vast quantities of medical images.
Read full description
Raidium employs a sophisticated AI technique known as Self-Supervised Learning (SSL). Unlike traditional supervised learning, which requires labeled data for training, SSL allows the AI to learn from large, unlabeled datasets. This makes the AI more versatile and capable of performing multiple tasks, such as analyzing different types of medical images. Additionally, Raidium's AI is multimodal, meaning it can process various types of inputs, including text, images, and sound. This capability enhances its utility in diverse medical scenarios.
The primary clients of Raidium are healthcare providers, including hospitals and diagnostic centers, that seek to improve the accuracy and efficiency of their radiology departments. By integrating Raidium's AI platform, these institutions can better manage the overwhelming volume of medical images, leading to faster and more accurate diagnoses.
Raidium operates in the global healthcare market, with a particular focus on regions that are rapidly adopting AI technologies in medical practices. The company's business model revolves around offering its AI platform as a subscription-based service. Healthcare providers pay a recurring fee to access the platform, which includes regular updates and support. This model ensures a steady revenue stream for Raidium while providing continuous value to its clients.
Revenue is generated through subscription fees, and potentially through partnerships with medical institutions and research organizations. The company also ensures compliance with data protection regulations, such as the General Data Protection Regulation (GDPR), by pseudonymizing personal medical data to protect patient privacy.
At a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Roubaix, France
- Employees
- 52
- Open positions
- 2
- Dealroom signal
- 91.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biomarkers, Medical Imaging, Core AI, Precision Medicine
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $0 | — | Debiopharm Group | ↗ |
| SEED✓Equity / VC | Nov 2024 | $18M | $70M | Founders Future · Techmind VC · Newfund · Debiopharm Group | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Raidium is 5.2K monthly website visits, up 333.3% over the last three months. Raidium's team grew 30% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
European Innovation Council
Newfund
Kurma Partners
Founders Future
Techmind VC
Debiopharm Group
Galion.exe
Series A1 investor entered at this stage
EIC Fund
Other known investors3 additional known investors
21st by CentraleSupélec
Paris Biotech Santé
Sharpstone Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Raidium on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Raidium’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







